AOD 9604

What It Is

A modified fragment of human growth hormone, specifically amino acids 177-191 with a tyrosine addition. AOD 9604 was designed to isolate the fat-metabolizing activity of growth hormone without its growth-promoting or diabetogenic effects.

How It Works

AOD 9604 mimics the lipolytic region of GH

→

Stimulates lipase activity in adipose tissue

→

Triggers fat breakdown without affecting IGF-1 or insulin

→

Fat oxidation increases without growth-related side effects

What Researchers Study It For

Fat metabolism without growth stimulation

Adipose tissue lipolysis pathways

Metabolic safety profile investigations

GH fragment structure-activity research

Common Research Protocols

AOD 9604 is typically reconstituted from lyophilized powder with bacteriostatic water and administered via subcutaneous injection. In preclinical studies, it has been investigated in both oral and injectable formats. Research dosing varies by study design, with many protocols exploring fasted-state administration to maximize lipolytic activity.

Community Interest Areas

AOD 9604 draws research interest for its targeted approach to fat metabolism. Because it is a fragment of growth hormone rather than the full molecule, researchers study it as a way to isolate lipolytic effects without influencing blood sugar or stimulating tissue growth. It is frequently explored in combination with other metabolic peptides in multi-pathway protocols.

HGH 177-191 Modified C-terminal fragment of human growth hormone

Peer-Reviewed Preclinical research on lipolysis without IGF-1 or insulin effects

For research purposes only. Not intended for consumption, clinical application, or diagnostic use.

What It Is

How It Works

What Researchers Study It For

Common Research Protocols

Community Interest Areas

What Are Peptides?

Are Peptides Safe?